Regs Must Resist Bank OTC Lobbying, Says NYSE

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Regs Must Resist Bank OTC Lobbying, Says NYSE

Regulatory supervisors in Europe and the U.S. should resist the extensive lobbying of banks when trying to overhaul the over-the-counter derivatives market, according to Fraser Cowie, executive director of global business development for NYSE Liffe.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article